Randomized clinical trial to evaluate the effica... [J Med Virol. 2013] - PubMed - NCBI
www.ncbi.nlm.nih.gov
Thirty CFS patients with elevated IgG antibody titers against HHV-6 and EBV were randomized 2:1 to receive valganciclovir (VGCV) or placebo for 6 months